Advertisement

pp 1-20 | Cite as

Neurocognitive Complications of HIV Infection in Low-Income Countries

  • Alyssa VecchioEmail author
  • Ned Sacktor
  • Deanna Saylor
  • Kevin Robertson
Chapter
Part of the Current Topics in Behavioral Neurosciences book series

Abstract

There is a paucity of information on neurocognitive dysfunction in individuals with HIV in resource-limited regions, despite the fact that these areas have the greatest burden of infection. HIV-associated neurocognitive disorder (HAND) remains a common complication of HIV despite the use of effective antiretroviral therapy (ART). HAND is a major cause of morbidity of HIV+ individuals and is estimated to be the most prevalent form of neurocognitive impairment worldwide in young adults. This finding has drastic implications for the productivity and social engagement of young adults in the development of industry, education, and healthcare, which is particularly relevant in low-income countries. Building an infrastructure to examine the neurological and neuropsychological characteristics of HIV+ individuals in resource-limited settings (RLS) can advance the understanding of the unique contributing factors of HIV-1 clades in these regions of high prevalence, improve neurological monitoring, explore the CNS HIV reservoir, and provide key information on prevention/interventions to help manage/improve these neurological and neuropsychological complications.

Keywords

ART HIV HIV-associated neurocognitive disorder Low income countries Resource limited settings 

References

  1. Akolo C, Royal W, Cherner M et al (2014) Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neurovirol 20(4):380–387Google Scholar
  2. Antinori A et al (2007) Updated research nosology for HIV associated neurocognitive disorders. Neurology 69(18):1789–1799Google Scholar
  3. Awori V, Mativo P, Yonga G, Shah R (2018) The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus. S Afr J HIV Med 19(1):674Google Scholar
  4. Belete T, Medfu G, Yemiyamrew E (2017) Prevalence of HIV associated neurocognitive deficit among HIV positive people in Ethiopia: a cross sectional study at Ayder Referral Hospital. Ethiop J Health Sci 27(1):67–76Google Scholar
  5. Benedict RH, Mezhir JJ, Walsh K, Hewitt RG (2000) Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol 15(6):535–544Google Scholar
  6. Bigna JJ, Um LN, Asangbeh SL, Sibetcheu AT, Kazé AD, Nansseu JR (2018) Prevalence and incidence of major depressive disorders among people living with HIV residing in Africa: a systematic review and meta-analysis protocol. Syst Rev 7(1):6Google Scholar
  7. Brandt R (2009) The mental health of people living with HIV/AIDS in Africa: a systematic review. Afr J AIDS Res 8:123–133Google Scholar
  8. Chan P, Tokac U, Hellmuth J, Kroon E, Colby D, Sacdalan C, Fletcher J, Tipsuk S, Pinyakorn S, Robb ML, Ananworanich J, Valcour V, Spudich S, Paul R (2018) Longitudinal cognitive outcomes after treatment in acute HIV infection. In: Conf. retroviruses opportunistic infect. Abstract 2018Google Scholar
  9. Chibanda D, Benjamin L, Weiss HA, Abas M (2014) Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries. J Acquir Immune Defic Syndr 67(Suppl 1):S54–S67Google Scholar
  10. Cournos F, McKinnon K, Pinho B, Waineberg ML (2014) Special populations and public health aspects. In: Joska JA, Stein DJ, Grant I (eds) HIV/AIDS and psychiatry. Wiley, West Essex, pp 211–234Google Scholar
  11. Cysique LA, Dermody N, Carr A, Brew BJ, Teesson M (2016) The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults. J Neurovirol 22(1):56–65Google Scholar
  12. de Almeida SM, Kamat R, Cherner M et al (2017) Improving detection of HIV-associated cognitive impairment: comparison of the international HIV dementia scale and a brief screening battery. J Acquir Immune Defic Syndr 74(3):332–338Google Scholar
  13. De Ronchi D, Faranca I, Berardi D et al (2002) Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Arch Neurol 59:812–818Google Scholar
  14. Doyle KL, Morgan EE, Morris S et al (2013) Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol 19(6):565–573Google Scholar
  15. Estiasari R, Lastri N (2015) Cognitive impairment among Indonesia HIV naïve patients. Neurol Asia 20(2):155–160Google Scholar
  16. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y et al (2005) Global prevalence of dementia: a delphi consensus study. Lancet 366:2112–2117Google Scholar
  17. Food and Agriculture Organization of the United Nations (2001) Rural women carry family burdens. Focus, AIDS – a threat to rural Africa. FAO, RomeGoogle Scholar
  18. Ghate M, Mehendale S, Meyer R et al (2015) The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India. J Neurovirol 21(4):391–398Google Scholar
  19. Gouws E, Cuchi P, on behalf of the International Collaboration on Estimating HIV Incidence by Modes of Transmission (2012) Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect 88(Suppl_2):i76–i85.  https://doi.org/10.1136/sextrans-2012-050719CrossRefGoogle Scholar
  20. Grant I, Franklin DJ, Deutsch R et al (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 10:2055–2062Google Scholar
  21. Habib AG, Yakasai AM, Owolabi LF, Ibrahim A, Habib ZG, Gudaji M, Karaye KM, Ibrahim DA, Nashabaru I (2013) Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis 17(10):e820–e831Google Scholar
  22. Heaps J, Valcour V, Chalermchai T, Paul R, Rattanamanee S et al (2012) Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol 35(1):1–8Google Scholar
  23. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(3):317–331Google Scholar
  24. Heaton RK, Cysique LA, Jin H et al (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol 14(6):536–549Google Scholar
  25. Heaton R et al (2010) HIV-associated neurocognitive disorders (HAND) persist in the era of potent antiretroviral therapy: the CHARTER study. Neurology 75:2087–2096Google Scholar
  26. Heaton RK, Franklin DR, Ellis RJ et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral disorders before and during the era of combination arntiretroviral therapy; differences in rates, nature, and predictors. J Neurovirol 17(1):3–16Google Scholar
  27. Heaton R et al (2012) Aging amplifies HIV neurocognitive impairment: the effects may be related to vascular and metabolic factors. J Neurovirol 17(1):3–16Google Scholar
  28. Hestad KA, Chinyama J, Anitha MJ, Ngoma MS et al (2019) Cognitive impairment in zambians with HIV infection and pulmonary tuberculosis. JAIDS 80(1):110–117Google Scholar
  29. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B et al (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373:795–807Google Scholar
  30. Joska JA, Westgarth-Taylor J, Hoare J et al (2011) Validity of the international HIV dementia scale in South Africa. AIDS Patient Care STDs 25:95–101Google Scholar
  31. Joska JA et al (2012) Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis 12(1):39Google Scholar
  32. Jumare J, El-Kamary SS, Magder L et al (2018) Body mass index and cognitive function among HIV-1 infected individuals in China, India and Nigeria. J Acquir Immune Defic Syndr 80(2):e30–e35Google Scholar
  33. Kabuba N, Menon JA, Franklin DR Jr, Heaton RK, Hestad KA (2016) HIV- and AIDS-associated neurocognitive functioning in Zambia – a perspective based on differences between the genders. Neuropsychiatr Dis Treat 12:2021–2028Google Scholar
  34. Kabuba N, Menon JA, Franklin DR Jr, Lydersen S, Heaton RK, Hestad KA (2018) Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology 32(5):519–528Google Scholar
  35. Kaharuza FM, Bunnell R, Moss S et al (2006) Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav 10(Suppl 1):105Google Scholar
  36. Kalula S, Petros G (2011) Responses to dementia in less developed countries with a focus on South Africa. Glob Aging 7:31–40Google Scholar
  37. Kamat R, McCutchan A, Kumarasamy N et al (2017) Neurocognitive functioning among HIV-positive adults in southern India. J Neurovirol 23:750Google Scholar
  38. Kanmogne GD, Kuate CT, Cysique LA et al (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60Google Scholar
  39. Kisakye A, Saylor D, Sacktor N et al (2018) Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda. AIDS Care 15:1–4.  https://doi.org/10.1080/09540121.2018.1557591CrossRefGoogle Scholar
  40. Langa KM, Larson EB, Crimmins EM et al (2017) A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 177(1):51–58Google Scholar
  41. Lawler K et al (2010) Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc 13:15Google Scholar
  42. Lescure FX, Omland LH, Engsig FN, Roed C, Gerstoft J, Pialoux G, Kronborg G, Larsen CS, Obel N (2011) Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis 52(2):235–243Google Scholar
  43. Liner KJ 2nd, Hall CD, Robertson KR (2007) Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol 13(4):291–304Google Scholar
  44. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K et al (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23(11):1359–1366Google Scholar
  45. Marwick KF, Kaaya SF (2010) Prevalence of depression and anxiety disorders in HIV-positive outpatients in rural Tanzania. AIDS Care 22(4):415–419Google Scholar
  46. Mayston R, Kinyanda E, Chishinga N, Prince M, Patel V (2012) Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review. AIDS 26:S117–S135Google Scholar
  47. Mayston R, Lazarus A, Patel V, Abas M, Korgaonkar P, Paranjape R et al (2016) Pathways to HIV testing and care in Goa, India: exploring psychosocial barriers and facilitators using mixed methods. BMC Public Health 16(1):765Google Scholar
  48. Meffert SM, Neylan TC, McCulloch CE, Maswai JJ, Owuoth J, Kiweewa F, Maganga L, Valcour V, Ake J (2018) Depression is independently associated with near doubling of HIV viral load. In: Conf. retroviruses opportunistic infect. Abstract 2018Google Scholar
  49. Milanini B, Allen IE, Bahemana E, Adamu Y, Kiweewa F, Maswai JJ, Owuoth J, Polyak C, Julie Ake J, Valcour V (2018) Predictors of HIV-related cognitive impairment in East Africa. In: Conf. retroviruses opportunistic infect. Abstract 2018Google Scholar
  50. Mohammadi D (2011) Neurology in resource-poor countries: fighting for funding. Lancet Neurol 10:953–954Google Scholar
  51. Morgan EE, Woods SP, Smith C et al (2012) AIDS Behav 16:2279Google Scholar
  52. Mukherjee T, Sakthivel R, Fong HY et al (2018) Utility of using the Montreal cognitive assessment (MoCA) as a screening tool for HIV-associated neurocognitive disorders (HAND) in multi-ethnic Malaysia. AIDS Behav 22(10):3226–3233Google Scholar
  53. Njamnshi AK, Bissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN et al (2009) Risk factors for HIV-associated neurocognitive disorders (HAND) in Sub-Saharan Africa: the case of Yaoundé, Cameroon. J Neurol Sci 285:149–153Google Scholar
  54. Parcesepe AM, Tymejczyk O, Remien RH, Gadisa T, Kulkarni S, Hoffman S, Melaku Z, Elul B, Nash D (2018a) Psychological distress, health and treatment-related factors among individuals initiating ART in Oromia, Ethiopia. AIDS Care 30(3):338–342Google Scholar
  55. Parcesepe A, Tymejczyk O, Remien R, Gadisa T, Kulkarni S, Hoffman S, Melaku Z, Elul B, Nash D (2018b) HIV-related stigma, social support, and psychological distress among individuals initiating ART in Ethiopia. AIDS Behav 22(12):3815–3825Google Scholar
  56. Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8:273–278Google Scholar
  57. Robertson K, Liner J, Heaton R (2009) Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev 19:232–249Google Scholar
  58. Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Group, A. C. T et al (2012) Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis 55(6):868–876Google Scholar
  59. Robertson K, Jiang H, Evans S et al (2016) International neurocognitive normative study: neurocognitive comparison data in diverse resource limited settings: AIDS Clinical Trials Group A5271. J Neurovirol 22(4):472–478Google Scholar
  60. Robertson K, Lama J, Pilcher C, Rios J, Brandes P, Ruiz E et al (2017) Can we afford to wait? ART and the CNS. In: Conf. retroviruses opportunistic infect. Abstract 2017Google Scholar
  61. Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB et al (2018) HIV-1 and TB co-infection in multinational resource limited settings: increased neurological dysfunction. Clin Infect Dis.  https://doi.org/10.1093/cid/ciy718Google Scholar
  62. Sacktor N, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374Google Scholar
  63. Sacktor N, Nakasujja N, Skolasky RL et al (2009) HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49(5):780–786Google Scholar
  64. Sacktor N, Nakasujja N, Redd AD, Manucci J, Laeyendecker O, Wendel SK et al (2014) HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis 29:261–268Google Scholar
  65. Sacktor N, Saylor D, Nakigozi G, Nakasujja N, Robertson KR, Grabwoski K, Kisakye A, Batte J, Mayanja R, Anok A, Gray RH, Wawer MJ (2019) Effect of HIV subtype and antiretroviral therapy on HIV-associated neurocognitive disorder (HAND) in Rakai, Uganda. JAIDS. in pressGoogle Scholar
  66. Sanmartí M, Meyer AC, Jaen A, Robertson K, Tan N, Samson L, Ndaki R, Battegay M, Tanner M, Dalmau D, Letang E (2018) Prevalence of HIV neurocognitive disorders in a rural Tanzanian cohort. In: Conf. retroviruses opportunistic infect. Abstract 2018Google Scholar
  67. Saylor D, Dickens AM, Sacktor N et al (2016) HIV-associated neurocognitive disorder – pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248Google Scholar
  68. Sevigny JJ, Albert S, McDermott M et al (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64(1):97–102Google Scholar
  69. Small J, Aldwin C, Kowal P, Chatterji S (2017) Aging and HIV-related caregiving in sub-Saharan Africa: a social ecological approach. Gerontologist.  https://doi.org/10.1093/geront/gnx159Google Scholar
  70. Spudich S, Gandhi R, Cyktor J, Lalama C, Bosch R, Macatangay B, Rinaldo C, Robertson K, Collier A, Godfrey C, Hogg E, Eron J, McMahon D, Mellors J (2018) HIV-1 persists in CSF cells in half of individuals on long term ART. In: 25th Conference on retroviruses and opportunistic infections (CROI), Boston, Mar 2018Google Scholar
  71. Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460Google Scholar
  72. Tedaldi EM, Minniti NL, Fischer T (2015) HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int 2015:641913Google Scholar
  73. Teitelman AM, Jemmott JB, Bellamy SL et al (2016) Partner violence, power, and gender differences in South African adolescents’ HIV/sexually transmitted infections risk behaviors. Health Psychol 35:751–760Google Scholar
  74. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45(2):174–182Google Scholar
  75. Troncoso FT, Conterno LO (2015) Prevalence of neurocognitive disorders and depression in a Brazilian HIV population. Rev Soc Bras Med Trop 48:390–398Google Scholar
  76. UNAIDS (2013) Report on the global AIDS epidemic 2013. UNAIDS, GenevaGoogle Scholar
  77. UNESCO Institute for Statistics (UIS) (2016) Youth literacyGoogle Scholar
  78. Wong M, Robertson K, Nakasujja N et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68:350–355Google Scholar
  79. World Bank (2017) The world bank atlas. World Bank, Washington, DCGoogle Scholar
  80. World Health Organization (2011) Mental health atlas. World Health Organization, GenevaGoogle Scholar
  81. World Health Organization (2016) Estimated number of people living with HIV, by WHO region, static mapGoogle Scholar
  82. World Health Organization (2017) Global tuberculosis reportGoogle Scholar
  83. Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, Brayne C (2016) Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 15:116–124Google Scholar
  84. Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate D, Solomon S, Flanigan T (2006) Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 12:424–430Google Scholar
  85. Yusuf AJ et al (2017) Prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in Northern Nigeria. J Int Assoc Provid AIDS Care 16(1):48–55Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alyssa Vecchio
    • 1
    Email author
  • Ned Sacktor
    • 2
  • Deanna Saylor
    • 2
  • Kevin Robertson
    • 3
  1. 1.Vita-Salute San Raffaele UniversityMilanItaly
  2. 2.Johns Hopkins UniversityBaltimoreUSA
  3. 3.AIDS Neurological Center, Neurology, UNCChapel HillUSA

Personalised recommendations